NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,386,000 | -5.2% | 285,716 | +22.1% | 0.16% | -10.9% |
| Q2 2018 | $1,462,000 | -24.6% | 233,972 | +0.1% | 0.18% | -28.2% |
| Q1 2018 | $1,940,000 | -22.9% | 233,762 | -5.2% | 0.26% | -23.2% |
| Q4 2017 | $2,515,000 | +15.4% | 246,523 | +3.5% | 0.33% | +12.2% |
| Q3 2017 | $2,179,000 | +55.6% | 238,152 | +24.2% | 0.30% | +48.0% |
| Q2 2017 | $1,400,000 | – | 191,729 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|